Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Emerg Infect Dis ; 24(8): 1565-1568, 2018 08.
Artigo em Inglês | MEDLINE | ID: mdl-30016242

RESUMO

Dengue virus and Zika virus coexist in tropical regions in Asia where healthcare resources are limited; differentiating the 2 viruses is challenging. We showed in a case-control discovery cohort, and replicated in a validation cohort, that the diagnostic indices of conjunctivitis, platelet count, and monocyte count reliably distinguished between these viruses.


Assuntos
Dengue/diagnóstico , Infecção por Zika virus/diagnóstico , Adulto , Aedes/virologia , Idoso , Animais , Estudos de Casos e Controles , Estudos de Coortes , Conjuntivite Viral/diagnóstico , Conjuntivite Viral/fisiopatologia , Conjuntivite Viral/virologia , Dengue/fisiopatologia , Dengue/transmissão , Dengue/virologia , Vírus da Dengue , Diagnóstico Diferencial , Feminino , Febre/diagnóstico , Febre/fisiopatologia , Febre/virologia , Humanos , Contagem de Leucócitos , Masculino , Pessoa de Meia-Idade , Mosquitos Vetores/virologia , Mialgia/diagnóstico , Mialgia/fisiopatologia , Mialgia/virologia , Contagem de Plaquetas , Curva ROC , Singapura , Zika virus , Infecção por Zika virus/fisiopatologia , Infecção por Zika virus/transmissão , Infecção por Zika virus/virologia
2.
BMC Infect Dis ; 15: 391, 2015 Sep 29.
Artigo em Inglês | MEDLINE | ID: mdl-26419926

RESUMO

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) poses an increasingly large disease and economic burden worldwide. The effectiveness of screening programs in the tropics is poorly understood. The aims of this study are: (i) to analyze the factors affecting MRSA colonization at admission and acquisition during hospitalization and (ii) to evaluate the cost-effectiveness of a screening program which aims to control MRSA incidence during hospitalization. METHODS: We conducted a retrospective case-control study of patients admitted to the Communicable Disease Centre (CDC) in Singapore between Jan 2009 and Dec 2010 when there was an ongoing selective screening and isolation program. Risk factors contributing to MRSA colonization on admission and acquisition during hospital stay were evaluated using a logistic regression model. In addition, a cost-effectiveness analysis was conducted to determine the cost per disability-adjusted life year (DALY) averted due to implementing the screening and isolation program. RESULTS: The average prevalence rate of screened patients at admission and the average acquisition rate at discharge during the study period were 12.1 and 4.8 % respectively. Logistic regression models showed that older age (adjusted odds ratio (OR) 1.03, 95 % CI 1.02-1.04, p < 0.001) and dermatological conditions (adjusted OR 1.49, 95 % CI 1.11-1.20, p = 0.008) were independently associated with an increased risk of MRSA colonization at admission. Age (adjusted OR 1.02, 95 % CI 1.01-1.03, p = 0.002) and length of stay in hospital (adjusted OR 1.04, 95 % CI 1.03-1.06, p < 0.001) were independent factors associated with MRSA acquisition during hospitalization. The screening and isolation program reduced the acquisition rate by 1.6 % and was found to be cost saving. For the whole study period, the program cost US$129,916, while it offset hospitalization costs of US$103,869 and loss of productivity costs of US$50,453 with -400 $/DALY averted. DISCUSSION: This study is the first to our knowledge that evaluates the cost-effectiveness of screening and isolation of MRSA patients in a tropical country. Another unique feature of the analysis is the evaluation of acquisition rates among specific types of patients (dermatological, HIV and infectious disease patients)and the comparison of the cost-effectiveness of screening and isolation between them. CONCLUSIONS: Overall our results indicate high MRSA prevalence that can be cost effectively reduced by selective screening and isolation programs in Singapore.


Assuntos
Portador Sadio/epidemiologia , Infecção Hospitalar/prevenção & controle , Tempo de Internação/estatística & dados numéricos , Programas de Rastreamento/economia , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Isolamento de Pacientes/economia , Dermatopatias/epidemiologia , Infecções Estafilocócicas/prevenção & controle , Adolescente , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Portador Sadio/diagnóstico , Estudos de Casos e Controles , Análise Custo-Benefício , Feminino , Hospitalização , Hospitais , Humanos , Incidência , Modelos Logísticos , Masculino , Resistência a Meticilina , Pessoa de Meia-Idade , Razão de Chances , Prevalência , Estudos Retrospectivos , Fatores de Risco , Singapura/epidemiologia , Dermatopatias/diagnóstico , Infecções Estafilocócicas/diagnóstico , Infecções Estafilocócicas/epidemiologia , Adulto Jovem
3.
Ann Acad Med Singap ; 39(6): 448-52, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20625620

RESUMO

INTRODUCTION: Outbreaks of acute respiratory illness occur commonly in long-term care facilities (LTCF), due to the close proximity of residents. Most influenza outbreak reports have been from temperate countries. This study reports an outbreak of influenza B among a highly immunised resident population in a welfare home in tropical Singapore, and discusses vaccine efficacy and the role of acute respiratory illness surveillance for outbreak prevention and control. MATERIALS AND METHODS: During the period from 16 to 21 March 2007, outbreak investigations and active case finding were carried out among residents and nursing staff at the welfare home. Interviews and medical notes review were conducted to obtain epidemiological and clinical data. Hospitalised patients were tested for respiratory pathogens. Further genetic studies were also carried out on positive respiratory samples. RESULTS: The overall clinical attack rate was 9.4% (17/180) in residents and 6.7% (2/30) in staff. All infected residents and staff had received influenza immunisation. Fifteen residents were hospitalised, with 2 developing severe complications. Genetic sequencing revealed that the outbreak strain had an 8.2% amino acid difference from B/Malaysia/2506/2004, the 2006 southern hemisphere influenza vaccine strain, which the residents and staff had earlier received. CONCLUSIONS: A mismatch between the vaccine and circulating influenza virus strains can result in an outbreak in a highly immunised LTCF resident population. Active surveillance for acute respiratory illness in LTCFs could be implemented for rapid detection of antigenic drift. Enhanced infection control and other preventive measures can then be deployed in a timely manner to mitigate the effect of any outbreaks.


Assuntos
Surtos de Doenças/prevenção & controle , Vírus da Influenza B/imunologia , Influenza Humana/epidemiologia , Influenza Humana/prevenção & controle , Seguridade Social , Adulto , Idoso , Feminino , Humanos , Vacinas contra Influenza/uso terapêutico , Influenza Humana/virologia , Entrevistas como Assunto , Masculino , Auditoria Médica , Pessoa de Meia-Idade , Casas de Saúde , Singapura/epidemiologia , Adulto Jovem
4.
Emerg Infect Dis ; 12(1): 95-102, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16494724

RESUMO

We compared strategies for stock piling neuraminidase inhibitors to treat and prevent influenza in Singapore. Cost-benefit and cost-effectiveness analyses, with Monte Carlo simulations, were used to determine economic outcomes. A pandemic in a population of 4.2 million would result in an estimated 525-1,775 deaths, 10,700-38,600 hospitalization days, and economic costs of 0.7 dollars to 2.2 billion Singapore dollars. The treatment-only strategy had optimal economic benefits: stock piles of antiviral agents for 40% of the population would save an estimated 418 lives and 414 million dollars, at a cost of 52.6 million dollars per shelf-life cycle of the stock pile. Prophylaxis was economically beneficial in high-risk subpopulations, which account for 78% of deaths, and in pandemics in which the death rate was >0.6%. Prophylaxis for pandemics with a 5% case-fatality rate would save 50,000 lives and 81 billion dollars. These models can help policymakers weigh the options for pandemic planning.


Assuntos
Antivirais/economia , Antivirais/provisão & distribuição , Surtos de Doenças , Influenza Humana/tratamento farmacológico , Neuraminidase/antagonistas & inibidores , Antivirais/uso terapêutico , Análise Custo-Benefício , Tomada de Decisões , Surtos de Doenças/prevenção & controle , Humanos , Influenza Humana/economia , Influenza Humana/epidemiologia , Singapura/epidemiologia , Taxa de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA